$104.77
-2.92-2.71%
At close: Sep 14, 5:00 PM EST
$105.21
-2.48-2.3%
Pre-Market: 8:31 AM EST
Dianthus Therapeutics Inc
DNTHNASDAQ
Dianthus Therapeutics Earnings & Forecasts
Dianthus Therapeutics (DNTH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Dianthus Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.91 | $-1.12 | $-1.01 | $-0.88 |
| Actual | $-0.90 | $-0.85 | $-1.43 | $-0.97 |
| Surprise | +1.10% | +24.1% | -41.6% | -10.2% |
| Revenue | ||||
| Estimate | $293000 | $396952 | $476950 | $578184 |
| Actual | $761000 | $463000 | $284000 | $396000 |
| Surprise | +159.7% | +16.6% | -40.5% | -31.5% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.96 | $-1.10 | $-1.09 | $-1.15 |
| Revenue | ||||
| Consensus | $388152 | $376256 | — | — |
